Fichit

Année :

2004

Nom Président :

Kostas KOSMATOPOULOS

Lieu :

Chargement de la carte ...

Employés :

5

PhD :

4

Cotation :

Non cotée

Total Equity funds raised since funding :

4

Total grants received :

0.86

R&D (average annual spending) :

4

Lien Site :

http://vaxon-biotech.com/

Résumé :

VAXON Biotech is a private company, located in Paris – France, that was founded in 2004. The company develops innovative therapeutic vaccines for the treatment of cancers including lung, gastric, prostate, breast, renal, liver and colorectal cancers, using its proprietary technology of optimized cryptic peptides.

Vaxon Biotech’s therapeutic vaccines are intended to treat existing cancers by stimulating the immune system to recognize and attack human cancer cells without harming normal cells. VAXON’s vaccines utilize proprietary optimized cryptic peptides and target universal tumor antigens that are highly overexpressed in a wide range of tumors while being present in very low quantities in normal tissues.

VAXON BIOTECH